ストックスクリーナーアプリを入手
27.37
1.07%
0.29
Pfizer Inc (PFE) 最新ニュース
Can Pfizer's Stock Break This Disappointing Streak? - AOL.com
Bank of America Securities Maintains Buy on Pfizer Inc (PFE) - Yahoo Finance
President Trump was undaunted getting Pfizer deal: Dr. Oz - NewsNation
ThinkCareBelieve: Week 37 America Isn’t Stopping - GlobeNewswire Inc.
Pfizer (PFE) Surges Following Landmark Drug Pricing Deal - GuruFocus
Pfizer – TrumpRx deal boosts Big Pharma to a record rally - Seeking Alpha
Pfizer’s AI Revolution: A New Era for Drug Discovery and Pharmaceutical Innovation - FinancialContent
Tech stocks roll on and Pfizer soars after Trump deal - Yahoo Finance
Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know - sharewise.com
5 Large Cap Drug Stocks: Values or Traps? - The Globe and Mail
The Score: Pfizer, Tesla, Electronic Arts and More Stocks That Defined the Week - MSN
B of A Securities Maintains Pfizer (PFE) Neutral Recommendation - Nasdaq
Pharma Stocks Eye Best Week in 16 Years as Trump Overhang Eases - Bloomberg.com
Wall Street Hits Record Highs As Rate Cut Bets Offset Shutdown: This Week In MarketsPfizer (NYSE:PFE) - Benzinga
What TrumpRx Means for Pfizer Stock and Pharma Investors - Stansberry Research
How Trump’s 100% Tariff Threat Forced Pfizer’s Hand — Inside The High-Stakes Talks That Changed Big Pharma’s Course - Stocktwits
Pfizer (PFE) Experiences Bullish Activity as Options Volume Surges - GuruFocus
Gallego demands transparency in Trump’s deal with Pfizer - The Hill
Trump administration announces MFN drug pricing deal with Pfizer - Yahoo Finance
Pink Sheet Podcast: Government Shutdown’s Impact On US FDA, Pfizer Inks Drug Pricing Deal - insights.citeline.com
Is PFE Stock a Buy After 14% Rise Post Drug Pricing Deal With Trump? - The Globe and Mail
MRK Stock Up Nearly 14% So Far This Week: What's Driving It? - The Globe and Mail
Pfizer’s drug-price deal with Trump ended months of deadlock - The Edge Malaysia
Weekly Rundown: TrumpRx unveils direct-to-consumer platform, Pfizer on board - Drug Discovery News
Pfizer (PFE) Is Up 14.7% After Landmark U.S. Drug Pricing and Tariff Exemption Deal - Yahoo Finance
Shareholders 26% loss in Pfizer (NYSE:PFE) partly attributable to the company's decline in earnings over past three years - Yahoo
How Trump Finally Cut a Deal With Big Pharma - Bloomberg.com
Pfizer (PFE) Secures Deal to Avert Tariffs Through U.S. Manufact - GuruFocus
Cantor Fitzgerald Maintains a Hold on Pfizer (PFE) - Yahoo Finance
MAHA supporters not on board with Trump’s Pfizer deal - The Hill
Eli Lilly And Its Competitors Pop On The Pfizer News - Real Investment Advice
Pfizer (PFE): Evaluating Valuation After Breakthrough U.S. Drug Pricing Deal Spurs Market Optimism - simplywall.st
Pfizer Just Made a Landmark Drug Pricing Agreement with President Donald Trump. Is the Stock a Buy? - Yahoo Finance
Pfizer’s Drug-Price Deal With Trump Followed Months of Deadlock - Bloomberg Law News
Exclusive | Inside Pfizer’s Drug-Pricing Deal With the Trump Administration - The Wall Street Journal
Inside Pfizer’s Drug-Pricing Deal With the Trump Administration - The Wall Street Journal
Pfizer Finally Gave Trump What He Wanted - AOL.com
FDA head says Trump-Pfizer deal to lower prescription drug costs is "major step" - CBS News
Health Care Down, Paring Gains From Pfizer Deal -- Health Care Roundup - MarketScreener
Trump administration pauses 100% import tax on drugs amid Pfizer negotiations - 13wham.com
Cartography Bio maps out cancer drug plan with $67 million from Pfizer, Amgen venture units and more - The Business Journals
View / Pfizer’s Oval Office show is the new face of pre-regulation - https-//www.semafor.com
How TrumpRx Website May Affect Your Drug Costs After Pfizer Deal - The New York Times
Pfizer Goes All In On TrumpRx. Is Pfizer Stock Now A Buy? - Investor's Business Daily
Pfizer Reaches Pricing Agreement With Trump Administration - Contract Pharma
Pfizer: The Long Suffering Is Finally Over (Rating Upgrade) (NYSE:PFE) - Seeking Alpha
Pfizer Stock, Other Drugmakers Rally Again - The Wall Street Journal
Why Pfizer’s Trump Deal Is Good News for All of Big Pharma - The Wall Street Journal
Procter & Gamble Will Shut Down Business in Pakistan, Following Shell and Pfizer Exits - MSN
SHASQI STRENGTHENS BOARD OF DIRECTORS WITH THE APPOINTMENT OF FORMER CHIEF DEVELOPMENT OFFICER AT PFIZER ONCOLOGY - BioSpace
Procter & Gamble will shut down business in Pakistan, following Shell and Pfizer exits - The Economic Times
BMO Capital Maintains Outperform on Pfizer (PFE) Amid New Obesity Partnership - Yahoo Finance
PFIZER INC : Jefferies reaffirms its Buy rating - MarketScreener
Pfizer's drug pricing deal with Trump ratchets up pressure on other pharma companies - Axios
Pfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump - Griffin Daily News
Why Pfizer Stock Trounced the Market Today - AOL.com
Donald Trump's Pfizer deal could change how governments tackle medicine prices | Mint - Mint
Questions Persist About How Pfizer’s US Agreement Lowers Prices - insights.citeline.com
0.16%
0.36%
大文字化:
|
ボリューム (24 時間):